|
For the first time in its history, the National Science Board has ...
Drug Firms Tackle Drug Abuse Conflicting Conferences Fun With Numbers DOE Inspectors: No Paper Tigers Rowland Voted In At AAAS The pharmaceutical industry is finally picking up the ball on the development of medicines to treat drug abuse (The Scientist, Nov. 26, 1990, page 1). The Pharmaceutical Manufacturers Association has established a nine-member Commission on Medicines for the Treatment of Drug Dependence and Abuse to work with the National Institute of Drug Abuse to develop scree
|
For the first time in its history, the National Science Board has ...
A citizen science game explores how social choices and networks can influence how an illness moves through a population.
View this IssueLearn how a next-generation platform accelerates biological research by enabling high-throughput, spatially resolved multiomics profiling.
In this webinar, Imogen Binnian will share how AI and gene synthesis technology can accelerate the discovery and validation of novel disease traits.
Real-time imaging enhances fluorescence activated cell sorting (FACS) to help scientists overcome the cost and burden of validation.
New innovations provide scientists with easy access to robust and accurate control samples for quality control applications.
Setting new standards for intelligent mass detection, sensitivity, and sustainability.
The Wellcome Sanger Institute, Helmholtz Munich, and Parse Biosciences have announced a landmark international collaboration to create a Cancer Plasticity Atlas.
Multi-center project will profile over 40,000 samples using ultra-sensitive NULISA™ technology.
Discover how Alderley Analytical meet regulatory demands and high-throughput challenges—processing 10,000+ dirty samples with consistent performance of the Xevo TQ Absolute XR Mass Spectrometer.